My Quote Request
6505-01-285-4590
20 Products
NDC39769-0011-05
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505012854590
NSN
6505-01-285-4590
NDC39769-0011-05
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505012854590
NSN
6505-01-285-4590
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS HEPARIN SODIUM PER MILLILITER
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: SINGLE DOSE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
7335
SOMATREM FOR INJECTION
NSN, MFG P/N
6505012855743
NSN
6505-01-285-5743
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOMATROPIN FOR INJECTION VIAL 6S
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAL CONTAINS 5 MG SOMATROPIN,25 MG MANNITOL,5 MG GLYCINE,AND 1.13 DIBASIC SODIUM PHOSPHATE; PH APPROXIMATELY 7.5 WHEN RECONSTITUTED; EACH VIAL IS SUPPLIED IN COMBINATION WITH 5 ML VIAL OF DILUTING SOLUTION OF WATER FOR INJECTION AS A UNIT; 6 UNITS PER
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: PACKAGE
Related Searches:
HUMATROPE
SOMATREM FOR INJECTION
NSN, MFG P/N
6505012855743
NSN
6505-01-285-5743
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOMATROPIN FOR INJECTION VIAL 6S
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAL CONTAINS 5 MG SOMATROPIN,25 MG MANNITOL,5 MG GLYCINE,AND 1.13 DIBASIC SODIUM PHOSPHATE; PH APPROXIMATELY 7.5 WHEN RECONSTITUTED; EACH VIAL IS SUPPLIED IN COMBINATION WITH 5 ML VIAL OF DILUTING SOLUTION OF WATER FOR INJECTION AS A UNIT; 6 UNITS PER
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: PACKAGE
Related Searches:
HUMATROPE INJECTION
SOMATREM FOR INJECTION
NSN, MFG P/N
6505012855743
NSN
6505-01-285-5743
HUMATROPE INJECTION
SOMATREM FOR INJECTION
NSN, MFG P/N
6505012855743
NSN
6505-01-285-5743
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOMATROPIN FOR INJECTION VIAL 6S
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAL CONTAINS 5 MG SOMATROPIN,25 MG MANNITOL,5 MG GLYCINE,AND 1.13 DIBASIC SODIUM PHOSPHATE; PH APPROXIMATELY 7.5 WHEN RECONSTITUTED; EACH VIAL IS SUPPLIED IN COMBINATION WITH 5 ML VIAL OF DILUTING SOLUTION OF WATER FOR INJECTION AS A UNIT; 6 UNITS PER
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: PACKAGE
Related Searches:
NDC00002-7335-16
SOMATREM FOR INJECTION
NSN, MFG P/N
6505012855743
NSN
6505-01-285-5743
NDC00002-7335-16
SOMATREM FOR INJECTION
NSN, MFG P/N
6505012855743
NSN
6505-01-285-5743
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOMATROPIN FOR INJECTION VIAL 6S
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAL CONTAINS 5 MG SOMATROPIN,25 MG MANNITOL,5 MG GLYCINE,AND 1.13 DIBASIC SODIUM PHOSPHATE; PH APPROXIMATELY 7.5 WHEN RECONSTITUTED; EACH VIAL IS SUPPLIED IN COMBINATION WITH 5 ML VIAL OF DILUTING SOLUTION OF WATER FOR INJECTION AS A UNIT; 6 UNITS PER
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: PACKAGE
Related Searches:
CLAFORAN IN ADD VANTAGE VIALS
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855745
NSN
6505-01-285-5745
CLAFORAN IN ADD VANTAGE VIALS
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855745
NSN
6505-01-285-5745
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFOTAXIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME SODIUM STERILE USP 2GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML GLASS VIAL HAVING A DOUBLE LEAD THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS: 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00039-0024-25
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855745
NSN
6505-01-285-5745
NDC00039-0024-25
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855745
NSN
6505-01-285-5745
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFOTAXIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME SODIUM STERILE USP 2GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML GLASS VIAL HAVING A DOUBLE LEAD THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS: 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
CLAFORAN IN ADD VANTAGE VIALS
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855746
NSN
6505-01-285-5746
CLAFORAN IN ADD VANTAGE VIALS
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855746
NSN
6505-01-285-5746
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFOTAXIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME SODIUM STERILE USP 1GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML GLASS VIAL HAVING A DOUBLE LEAD THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS; 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00039-0023-25
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855746
NSN
6505-01-285-5746
NDC00039-0023-25
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505012855746
NSN
6505-01-285-5746
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFOTAXIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME SODIUM STERILE USP 1GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML GLASS VIAL HAVING A DOUBLE LEAD THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS; 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-1130-91
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
NDC00469-1130-91
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS PENTAMIDINE ISETHIONATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTAMIDINE ISETHIONATE STERILE 300MG SINGLE DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: NONPYROGENIC; SUITABLE FOR RECONSTITUTION; IN A SINGLE-DOSE VIAL OF SUFFICIENT CAPACITY TO PERMIT RECONSTITUTION WITH 3-5 ML OF DILUENT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC57317-0211-03
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
NDC57317-0211-03
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS PENTAMIDINE ISETHIONATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTAMIDINE ISETHIONATE STERILE 300MG SINGLE DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: NONPYROGENIC; SUITABLE FOR RECONSTITUTION; IN A SINGLE-DOSE VIAL OF SUFFICIENT CAPACITY TO PERMIT RECONSTITUTION WITH 3-5 ML OF DILUENT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC63323-0113-10
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
NDC63323-0113-10
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS PENTAMIDINE ISETHIONATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTAMIDINE ISETHIONATE STERILE 300MG SINGLE DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: NONPYROGENIC; SUITABLE FOR RECONSTITUTION; IN A SINGLE-DOSE VIAL OF SUFFICIENT CAPACITY TO PERMIT RECONSTITUTION WITH 3-5 ML OF DILUENT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
PENTAM 300
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
PENTAM 300
PENTAMIDINE ISETHIONATE,STERILE
NSN, MFG P/N
6505012855747
NSN
6505-01-285-5747
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS PENTAMIDINE ISETHIONATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTAMIDINE ISETHIONATE STERILE 300MG SINGLE DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: NONPYROGENIC; SUITABLE FOR RECONSTITUTION; IN A SINGLE-DOSE VIAL OF SUFFICIENT CAPACITY TO PERMIT RECONSTITUTION WITH 3-5 ML OF DILUENT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
AYR SALINE NASAL DROPS
SODIUM CHLORIDE NASAL SOLUTION
NSN, MFG P/N
6505012855752
NSN
6505-01-285-5752
AYR SALINE NASAL DROPS
SODIUM CHLORIDE NASAL SOLUTION
NSN, MFG P/N
6505012855752
NSN
6505-01-285-5752
MFG
B F ASCHER & COMPANY INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.650 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE NASAL SOLUTION 50ML DROPPER BOTTLE 12S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00225-0382-80
SODIUM CHLORIDE NASAL SOLUTION
NSN, MFG P/N
6505012855752
NSN
6505-01-285-5752
NDC00225-0382-80
SODIUM CHLORIDE NASAL SOLUTION
NSN, MFG P/N
6505012855752
NSN
6505-01-285-5752
MFG
B F ASCHER & COMPANY INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.650 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE NASAL SOLUTION 50ML DROPPER BOTTLE 12S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00054-4301-29
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505012855756
NSN
6505-01-285-5756
NDC00054-4301-29
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505012855756
NSN
6505-01-285-5756
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC62794-0464-88
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012856007
NSN
6505-01-285-6007
NDC62794-0464-88
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012856007
NSN
6505-01-285-6007
MFG
SZY HOLDINGS LLC DBA EVER READY FIRST AID & MEDICAL SUPPLIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 37.500 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
11673
CHLORPROPAMIDE TABLETS,USP
NSN, MFG P/N
6505012856408
NSN
6505-01-285-6408
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLORPROPAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1852-10
CHLORPROPAMIDE TABLETS,USP
NSN, MFG P/N
6505012856408
NSN
6505-01-285-6408
NDC00182-1852-10
CHLORPROPAMIDE TABLETS,USP
NSN, MFG P/N
6505012856408
NSN
6505-01-285-6408
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLORPROPAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00173-0434-00
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012857473
NSN
6505-01-285-7473
NDC00173-0434-00
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012857473
NSN
6505-01-285-7473
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 1GM VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL WITH DOUBLE LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715; EACH VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD; 118 MG SODIUM CARBONATE